Vlad Coric
Chairman & Chief Executive Officer at Biohaven Β· Chairman & Chief Executive Officer at Biohaven Pharmaceuticals
New Haven, Connecticut, United States
Find your path to Vlad
68 people in our graph share verified history with Vlad β schools, employers, funds. One of them is your warm intro.
Karthik ArdhanareeswaranunlockedVlad: together at Yale School of Medicine (2012β2015)
Γ11Vlad: together at Yale School of Medicine
Chairman & Chief Executive Officer at Biohaven
Intro paths
β
In turn, Vlad can intro founders to Biohaven's investors below.
Chairman & Chief Executive Officer at Biohaven Pharmaceuticals
Intro paths
β
In turn, Vlad can intro founders to Biohaven Pharmaceuticals's investors below.
Biohaven Pharmaceuticals's investors Β· 6
Experience
- Biohaven LimitedCEO and Chairman Board of Directorscurrent2022 β present
- Yale School of MedicineAssociate Clinical Professorcurrent2006 β present
- Yale School of MedicineAssistant Clinical Professor2001 β 2006
- Biohaven Pharmaceutical Holding Company LimitedCEO and Chairman Board of Directors2015 β 2022
- Bristol-Myers SquibbGroup Director, Global Clinical Research2007 β 2015
Skills & more
Clinical ResearchNeuroscienceClinical TrialsPsychopharmacology20Clinical DevelopmentPsychiatry85Pharmacology85OncologyTranslational Medicine59Medical Education36Neurodegeneration10Public Health13
+8 more
MigraineInfectious DiseasesPharmaceutical IndustryDrug DevelopmentTherapeutic AreasNeurologyClinical MonitoringCBTLanguages Croatian
From Vlad's professional profile.
Frequently asked questions
- Who is Vlad Coric?
- Chairman & Chief Executive Officer at Biohaven Pharmaceuticals
- Where does Vlad Coric work?
- Vlad Coric is Chairman & Chief Executive Officer at Biohaven and Chairman & Chief Executive Officer at Biohaven Pharmaceuticals.
Shared employers
Also worked at Yale School of Medicine80
Karthik ArdhanareeswaranInvestor at GV (Google Ventures)Brittany de KouchkovskyDirector, University Relations at Osage University PartnersDavid Rosenthal, MDVenture Partner at AlleyCorpAlley (Welsh) OlshanskyAdvisor at Casdin CapitalSophie RobinsonSenior Associate at Cure VenturesMichael RechtChair, P2C Scientific Advisory Group and Chief Medical and Scientific Advisor at Pathway to Cures
+ 74 more
Also worked at Bristol-Myers Squibb158
Scott BillerInvestor at GV (Google Ventures)Avantika DaingFounding Partner at Plum Alley InvestmentsJake BauerVenture Partner at ARCH Venture PartnersScott DonohueSenior Director, Market Access at Deerfield Management CompanyMellissa GraySenior Scientist, Protein Sciences at Deerfield Management CompanyBeth SeidenbergFounding Managing Director at Westlake Village BioPartners
+ 152 more


















